These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Injectable Ketorolac and Corticosteroid Use in Athletes: A Systematic Review. Jelsema TR; Tam AC; Moeller JL Sports Health; 2020; 12(6):521-527. PubMed ID: 32877323 [TBL] [Abstract][Full Text] [Related]
3. Management of Pain in Elite Athletes: Identified Gaps in Knowledge and Future Research Directions. Zideman DA; Derman W; Hainline B; Moseley GL; Orchard J; Pluim BM; Siebert CH; Turner JA Clin J Sport Med; 2018 Sep; 28(5):485-489. PubMed ID: 29952840 [TBL] [Abstract][Full Text] [Related]
4. Do the pharmacodynamics of the nonsteroidal anti-inflammatory drugs suggest a role in the management of postoperative pain? Mather LE Drugs; 1992; 44 Suppl 5():1-12; discussion 13. PubMed ID: 1284557 [TBL] [Abstract][Full Text] [Related]
5. Athletes, NSAID, coxibs, and the gastrointestinal tract. Lilly KF Curr Sports Med Rep; 2010; 9(2):103-5. PubMed ID: 20220352 [TBL] [Abstract][Full Text] [Related]
6. Cyclo-oxygenase-2 inhibitors : beneficial or detrimental for athletes with acute musculoskeletal injuries? Warden SJ Sports Med; 2005; 35(4):271-83. PubMed ID: 15831058 [TBL] [Abstract][Full Text] [Related]
7. Analgesic and anti-inflammatory drugs in sports: Implications for exercise performance and training adaptations. Lundberg TR; Howatson G Scand J Med Sci Sports; 2018 Nov; 28(11):2252-2262. PubMed ID: 30102811 [TBL] [Abstract][Full Text] [Related]
8. Non-steroidal anti-inflammatory drugs for athletes: an update. Ziltener JL; Leal S; Fournier PE Ann Phys Rehabil Med; 2010 May; 53(4):278-82, 282-8. PubMed ID: 20363203 [TBL] [Abstract][Full Text] [Related]
9. Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol. Litalien C; Jacqz-Aigrain E Paediatr Drugs; 2001; 3(11):817-58. PubMed ID: 11735667 [TBL] [Abstract][Full Text] [Related]
10. Prophylactic use of NSAIDs by athletes: a risk/benefit assessment. Warden SJ Phys Sportsmed; 2010 Apr; 38(1):132-8. PubMed ID: 20424410 [TBL] [Abstract][Full Text] [Related]
11. Use of NSAIDs in triathletes: prevalence, level of awareness and reasons for use. Gorski T; Cadore EL; Pinto SS; da Silva EM; Correa CS; Beltrami FG; Kruel LF Br J Sports Med; 2011 Feb; 45(2):85-90. PubMed ID: 19666628 [TBL] [Abstract][Full Text] [Related]
12. The potential contributing effect of ketorolac and fluoxetine to a spinal epidural hematoma following a cervical interlaminar epidural steroid injection: a case report and narrative review. Chien GC; McCormick Z; Araujo M; Candido KD Pain Physician; 2014; 17(3):E385-95. PubMed ID: 24850120 [TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal anti-inflammatory drugs exposure and the central nervous system. Auriel E; Regev K; Korczyn AD Handb Clin Neurol; 2014; 119():577-84. PubMed ID: 24365321 [TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal Anti-Inflammatory Drugs in the Treatment of Retinal Diseases. Rodrigues EB; Farah ME; Bottós JM; Bom Aggio F Dev Ophthalmol; 2016; 55():212-20. PubMed ID: 26502088 [TBL] [Abstract][Full Text] [Related]
15. Injections and return to play. Dietzel DP; Hedlund EC Curr Sports Med Rep; 2004 Dec; 3(6):310-5. PubMed ID: 15509472 [TBL] [Abstract][Full Text] [Related]
16. Epidemiological profile of pain and non-steroid anti-inflammatory drug use in collegiate athletes in the United States. Christopher S; Tadlock BA; Veroneau BJ; Harnish C; Perera NKP; Knab AM; Vallabhajosula S; Bullock GS BMC Musculoskelet Disord; 2020 Aug; 21(1):561. PubMed ID: 32814544 [TBL] [Abstract][Full Text] [Related]
17. Challenges of pain masking in the management of soft tissue disorders: optimizing patient outcomes with a multi-targeted approach. Speed C; Wolfarth B Curr Med Res Opin; 2014 May; 30(5):953-9. PubMed ID: 24730542 [TBL] [Abstract][Full Text] [Related]